Elevated urinary catecholamines
|
phenotype |
|
Finding
|
8
|
|
0.100 |
None |
|
0 |
|
|
|
Nervous System Neoplasms
|
group |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
68
|
1
|
0.100 |
None |
|
0 |
|
|
|
Cutaneous Melanoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
507
|
248
|
0.300 |
None |
|
0 |
|
|
|
NEUROBLASTOMA, SUSCEPTIBILITY TO
|
phenotype |
|
Finding
|
11
|
34
|
0.100 |
None |
1.000 |
11 |
14
|
1990 |
2016 |
Lymphoma
|
group |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1548
|
91
|
0.100 |
None |
0.976 |
85 |
1
|
1994 |
2019 |
Lymphoma, Non-Hodgkin
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
733
|
197
|
0.100 |
None |
1.000 |
22 |
|
1994 |
2019 |
Childhood Non-Hodgkin Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
371
|
39
|
0.100 |
None |
1.000 |
16 |
|
1994 |
2019 |
Lymphoma, Non-Hodgkin, Familial
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
462
|
79
|
0.100 |
None |
1.000 |
15 |
|
1994 |
2019 |
Adult Non-Hodgkin Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
370
|
39
|
0.100 |
None |
1.000 |
14 |
|
1994 |
2019 |
Malignant transformation
|
phenotype |
|
Neoplastic Process
|
1027
|
20
|
0.060 |
None |
1.000 |
6 |
|
1994 |
2016 |
Ki-1+ Anaplastic Large Cell Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
300
|
10
|
0.600 |
None |
0.973 |
369 |
4
|
1995 |
2020 |
Hodgkin Disease
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
900
|
148
|
0.100 |
None |
0.923 |
26 |
|
1995 |
2018 |
Ewings sarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
517
|
25
|
0.030 |
None |
1.000 |
3 |
|
1995 |
2017 |
Immunologic Deficiency Syndromes
|
group |
Immune System Diseases
|
Disease or Syndrome
|
973
|
31
|
0.020 |
None |
1.000 |
2 |
|
1995 |
2013 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
0.979 |
517 |
15
|
1996 |
2020 |
Lymphomatoid Papulosis
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
34
|
|
0.070 |
None |
0.857 |
7 |
|
1996 |
2019 |
Lymphoproliferative Disorders
|
group |
Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
300
|
14
|
0.070 |
None |
1.000 |
7 |
|
1996 |
2019 |
Childhood Large Cell Lymphoma
|
disease |
|
Neoplastic Process
|
30
|
|
0.040 |
None |
0.750 |
4 |
|
1996 |
2001 |
Reticulosarcoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
80
|
2
|
0.030 |
None |
0.667 |
3 |
|
1996 |
1998 |
Malignant histiocytosis
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
19
|
2
|
0.010 |
None |
< 0.001 |
1 |
|
1996 |
1996 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.100 |
None |
0.970 |
169 |
7
|
1997 |
2020 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.100 |
None |
0.975 |
118 |
3
|
1997 |
2020 |
Childhood Anaplastic Large Cell Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
130
|
2
|
0.100 |
None |
0.991 |
107 |
|
1997 |
2020 |
Adult Anaplastic Large Cell Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
128
|
2
|
0.100 |
None |
0.990 |
105 |
|
1997 |
2020 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.100 |
None |
0.960 |
75 |
3
|
1997 |
2019 |